Eli Lilly published the results of its ATTAIN-1b trial for obesity in September 2025 7 , which compared orforglipron to placebo in more than 3,100 adults without diabetes, with a BMI of 30+ or 27-30 with an obesity-related complication including hypertension, dyslipidaemia, cardiovascular disease or obstructive sleep apnoea and a history of at least one patient-reported unsuccessful dietary effort to lose body weight, who have tried unsuccessfully to lose weight with diet alone
Botulinum toxin was used to improve dynamic wrinkles, while polynucleotides such as PolyPhil was used to improve skin texture
The effect of ginger (Zingiber officinale) on platelet aggregation: A systematic literature review
And, believe me, I don't take shortcuts." Williams told People magazine separately that, despite her new look, her confidence level has never wavered
People who have struggled with weight are finally finding relief in the form of a painless weekly injection
Consider how much ongoing contact you want with your healthcare provider